These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32277231)

  • 1. The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD.
    Kuc K; Bielecki M; Racicka-Pawlukiewicz E; Czerwinski MB; Cybulska-Klosowicz A
    Sci Rep; 2020 Apr; 10(1):6176. PubMed ID: 32277231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
    Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
    Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder.
    Brown AB; Biederman J; Valera EM; Doyle AE; Bush G; Spencer T; Monuteaux MC; Mick E; Whitfield-Gabrieli S; Makris N; LaViolette PS; Oscar-Berman M; Faraone SV; Seidman LJ
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):365-375. PubMed ID: 19676101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD.
    Dresler T; Ehlis AC; Heinzel S; Renner TJ; Reif A; Baehne CG; Heine M; Boreatti-Hümmer A; Jacob CP; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2010 Oct; 35(11):2193-202. PubMed ID: 20631685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.
    Spencer TJ; Biederman J; Faraone SV; Madras BK; Bonab AA; Dougherty DD; Batchelder H; Clarke A; Fischman AJ
    Biol Psychiatry; 2013 Jul; 74(2):84-9. PubMed ID: 23273726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.
    Grünblatt E; Werling AM; Roth A; Romanos M; Walitza S
    J Neural Transm (Vienna); 2019 Apr; 126(4):517-529. PubMed ID: 30923918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
    Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
    Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.
    Mazei-Robison MS; Couch RS; Shelton RC; Stein MA; Blakely RD
    Neuropharmacology; 2005 Nov; 49(6):724-36. PubMed ID: 16171832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder.
    Yang B; Chan RC; Jing J; Li T; Sham P; Chen RY
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):541-50. PubMed ID: 17440978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
    de Azeredo LA; Rovaris DL; Mota NR; Polina ER; Marques FZ; Contini V; Vitola ES; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
    Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):401-8. PubMed ID: 24487615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratask Variability As a Correlate for DRD4 and SLC6A3 Variants: A Pilot Study in ADHD.
    Henríquez-Henríquez M; Villarroel L; Henríquez H; Zamorano F; Rothhammer F; Aboitiz F
    J Atten Disord; 2015 Nov; 19(11):987-96. PubMed ID: 22930791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter genotype modulates brain activity during a working memory task in children with ADHD.
    Pineau G; Villemonteix T; Slama H; Kavec M; Balériaux D; Metens T; Baijot S; Mary A; Ramoz N; Gorwood P; Peigneux P; Massat I
    Res Dev Disabil; 2019 Sep; 92():103430. PubMed ID: 31306870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.
    Franke B; Vasquez AA; Johansson S; Hoogman M; Romanos J; Boreatti-Hümmer A; Heine M; Jacob CP; Lesch KP; Casas M; Ribasés M; Bosch R; Sánchez-Mora C; Gómez-Barros N; Fernàndez-Castillo N; Bayés M; Halmøy A; Halleland H; Landaas ET; Fasmer OB; Knappskog PM; Heister AJ; Kiemeney LA; Kooij JJ; Boonstra AM; Kan CC; Asherson P; Faraone SV; Buitelaar JK; Haavik J; Cormand B; Ramos-Quiroga JA; Reif A
    Neuropsychopharmacology; 2010 Feb; 35(3):656-64. PubMed ID: 19890261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD.
    Althaus M; Groen Y; Wijers AA; Minderaa RB; Kema IP; Dijck JD; Hoekstra PJ
    Biol Psychol; 2010 Sep; 85(1):19-32. PubMed ID: 20450954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD.
    Franke B; Hoogman M; Arias Vasquez A; Heister JG; Savelkoul PJ; Naber M; Scheffer H; Kiemeney LA; Kan CC; Kooij JJ; Buitelaar JK
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1576-9. PubMed ID: 18802924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of maternal and paternal smoking on attentional control in children with and without ADHD.
    Altink ME; Slaats-Willemse DI; Rommelse NN; Buschgens CJ; Fliers EA; Arias-Vásquez A; Xu X; Franke B; Sergeant JA; Faraone SV; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2009 Aug; 18(8):465-75. PubMed ID: 19288168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between a 3'UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients.
    Aparecida da Silva M; Cordeiro Q; Louzã M; Vallada H
    J Atten Disord; 2011 May; 15(4):305-9. PubMed ID: 20332413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.